Id |
Subject |
Object |
Predicate |
Lexical cue |
T64 |
0-7 |
Sentence |
denotes |
Results |
T65 |
8-134 |
Sentence |
denotes |
In the first investigation, we aimed to test whether viral positive can be found in anal swab and blood as well as oral swabs. |
T66 |
135-285 |
Sentence |
denotes |
We conducted a molecular investigation to patients in Wuhan pulmonary hospital, who were detected as oral swabs positive for 2019-nCoV upon admission. |
T67 |
286-396 |
Sentence |
denotes |
We collected blood, oral swabs and anal swabs for 2019-nCoV qPCR test using previously established method [5]. |
T68 |
397-477 |
Sentence |
denotes |
We found 15 patients who still carry virus following days of medical treatments. |
T69 |
478-621 |
Sentence |
denotes |
Of these patients, 8 were oral swabs positive (53.3%), 4 were anal swabs positive (26.7%), 6 blood positives (40%) and 3 serum positives (20%). |
T70 |
622-737 |
Sentence |
denotes |
Two patients were positive by both oral swab and anal swab, yet none of the blood positive was also swabs positive. |
T71 |
738-817 |
Sentence |
denotes |
Not surprisingly, all serum positives were also whole serum positive (Table 1). |
T72 |
818-926 |
Sentence |
denotes |
In summary, viral nucleotide can be found in anal swab or blood even if it cannot be detected in oral swabs. |
T73 |
927-1018 |
Sentence |
denotes |
It should be noted that although swabs may be negative, the patient might still be viremic. |
T74 |
1019-1027 |
Sentence |
denotes |
Table 1. |
T75 |
1028-1080 |
Sentence |
denotes |
Molecular detection of 2019-nCoV in swabs and blood. |
T76 |
1081-1142 |
Sentence |
denotes |
Samples were from oral swabs (OS), anal swabs (AS) and blood. |
T77 |
1143-1177 |
Sentence |
denotes |
Data were shown as qPCR Ct values. |
T78 |
1178-1239 |
Sentence |
denotes |
Patients in severe condition during investigation were shown. |
T79 |
1240-1280 |
Sentence |
denotes |
OS AS Whole blood Serum Severe disease |
T80 |
1281-1304 |
Sentence |
denotes |
Patient 1 33.5 No |
T81 |
1305-1332 |
Sentence |
denotes |
Patient 2 30.3 24.3 Yes |
T82 |
1333-1356 |
Sentence |
denotes |
Patient 3 30.3 No |
T83 |
1357-1380 |
Sentence |
denotes |
Patient 4 32.1 No |
T84 |
1381-1404 |
Sentence |
denotes |
Patient 5 33.1 No |
T85 |
1405-1428 |
Sentence |
denotes |
Patient 6 30.6 No |
T86 |
1429-1455 |
Sentence |
denotes |
Patient 7 32.7 30.2 No |
T87 |
1456-1479 |
Sentence |
denotes |
Patient 8 33.1 No |
T88 |
1480-1506 |
Sentence |
denotes |
Patient 9 31.4 34.5 No |
T89 |
1507-1535 |
Sentence |
denotes |
Patient 10 30.9 33.0 Yes |
T90 |
1536-1560 |
Sentence |
denotes |
Patient 11 27.3 No |
T91 |
1561-1586 |
Sentence |
denotes |
Patient 12 34.4 Yes |
T92 |
1587-1614 |
Sentence |
denotes |
Patient 13 32.9 33.6 No |
T93 |
1615-1639 |
Sentence |
denotes |
Patient 14 32.3 No |
T94 |
1640-1664 |
Sentence |
denotes |
Patient 15 31.6 No |
T95 |
1665-1833 |
Sentence |
denotes |
We then did another investigation to find out the dynamic changes of viral presence in two consecutive studies in both oral and anal swabs in another group of patients. |
T96 |
1834-1930 |
Sentence |
denotes |
The target patients were those who received around 10 days of medical treatments upon admission. |
T97 |
1931-2030 |
Sentence |
denotes |
We tested for both viral antibody and viral nucleotide levels by previously established method [5]. |
T98 |
2031-2143 |
Sentence |
denotes |
We showed that both IgM and IgG titres were relatively low or undetectable in day 0 (the day of first sampling). |
T99 |
2144-2347 |
Sentence |
denotes |
On day 5, an increase of viral antibodies can be seen in nearly all patients, which was normally considered as a transition from earlier to later period of infection (Figure 1 and supplementary table 1). |
T100 |
2348-2477 |
Sentence |
denotes |
IgM positive rate increased from 50% (8/16) to 81% (13/16), whereas IgG positive rate increased from 81% (13/16) to 100% (16/16). |
T101 |
2478-2570 |
Sentence |
denotes |
This is in contrast to a relatively low detection positive rate from molecular test (below). |
T102 |
2571-2580 |
Sentence |
denotes |
Figure 1. |
T103 |
2581-2616 |
Sentence |
denotes |
Serological detection of 2019-nCoV. |
T104 |
2617-2704 |
Sentence |
denotes |
Dashed line indicates cutoff, which was determined based on data from healthy controls. |
T105 |
2705-2818 |
Sentence |
denotes |
For molecular detection, we found 8 oral swabs positive (50%) and 4 anal swabs (25%) in these 16 people on day 0. |
T106 |
2819-2883 |
Sentence |
denotes |
On day 5, we were only able to find 4 oral swabs positive (25%). |
T107 |
2884-2936 |
Sentence |
denotes |
In contrast, we found 6 anal swabs positive (37.5%). |
T108 |
2937-3052 |
Sentence |
denotes |
When counting all swab positives together, we found most of the positives came from oral swab (8/10, 80%) on day 0. |
T109 |
3053-3100 |
Sentence |
denotes |
However, this trend appears to change on day 5. |
T110 |
3101-3180 |
Sentence |
denotes |
We found more (6/8, 75%) anal swab positive than oral swab positive (4/8, 50%). |
T111 |
3181-3280 |
Sentence |
denotes |
Another observation is the reoccurrence of virus in 6 patients who were detected negative on day 0. |
T112 |
3281-3350 |
Sentence |
denotes |
Of note, 4 of these 6 viral positives were from anal swabs (Table 2). |
T113 |
3351-3513 |
Sentence |
denotes |
These data suggested a shift from more oral positive during early period (as indicated by antibody titres) to more anal positive during later period might happen. |
T114 |
3514-3522 |
Sentence |
denotes |
Table 2. |
T115 |
3523-3589 |
Sentence |
denotes |
Molecular detection of 2019-nCoV in swabs from two investigations. |
T116 |
3590-3651 |
Sentence |
denotes |
Samples were from oral swabs (OS), anal swabs (AS) and blood. |
T117 |
3652-3686 |
Sentence |
denotes |
Data were shown as qPCR Ct values. |
T118 |
3687-3728 |
Sentence |
denotes |
Date 0-OS Date 0-AS Date 5-OS Date 5-AS |
T119 |
3729-3749 |
Sentence |
denotes |
Patient 1 23.2 |
T120 |
3750-3770 |
Sentence |
denotes |
Patient 2 30.3 |
T121 |
3771-3791 |
Sentence |
denotes |
Patient 3 19.5 |
T122 |
3792-3815 |
Sentence |
denotes |
Patient 4 32.7 30.2 |
T123 |
3816-3836 |
Sentence |
denotes |
Patient 5 33.1 |
T124 |
3837-3863 |
Sentence |
denotes |
Patient 6 31.1 30.0 31.4 |
T125 |
3864-3884 |
Sentence |
denotes |
Patient 7 27.3 |
T126 |
3885-3905 |
Sentence |
denotes |
Patient 8 27.0 |
T127 |
3906-3929 |
Sentence |
denotes |
Patient 9 32.9 33.6 |
T128 |
3930-3951 |
Sentence |
denotes |
Patient 10 23.8 |
T129 |
3952-3973 |
Sentence |
denotes |
Patient 11 31.9 |
T130 |
3974-3995 |
Sentence |
denotes |
Patient 12 32.3 |
T131 |
3996-4017 |
Sentence |
denotes |
Patient 13 17.8 |
T132 |
4018-4039 |
Sentence |
denotes |
Patient 14 25.5 |
T133 |
4040-4061 |
Sentence |
denotes |
Patient 15 30.0 |
T134 |
4062-4089 |
Sentence |
denotes |
Patient 16 33.8 26.9 27.5 |